Who’s hiring who? Hiring activity in the Asia-Pacific pharma industry increased by 2% in Q1 2023
The Asia-Pacific pharma industry experienced a 2% rise in new job postings in Q1 2023 compared with the previous quarter,…
The Asia-Pacific pharma industry experienced a 2% rise in new job postings in Q1 2023 compared with the previous quarter, with the highest share accounted for by Biocon with 8,387 job postings, according to GlobalData’s analysis of pharma company job postings. Buy the report here.
Notably, Management Occupations jobs accounted for a 20% share of the Asia-Pacific pharma industry’s total new job postings in Q1 2023, rise 20% over the prior quarter.
Management Occupations drive pharma hiring activity
Management Occupations, with a share of 20% new job postings, was the occupation with the greatest hiring activity in the Asia-Pacific pharma industry in Q1 2023 , ahead of Life, Physical, and Social Science Occupations with a 14% share of new job postings.
The other prominent roles included Healthcare Practitioners and Technical Occupations with a 7% share in Q1 2023, Computer and Mathematical Occupations with a 6% share and Business and Financial Operations Occupations with a 3% share of new job postings.
Top five companies accounted for 67% of hiring activity
Biocon posted 8,387 jobs in Q1 2023 and registered a growth of 198% over the previous quarter, followed by Novartis with 1,240 jobs and a 78% growth. Takeda Pharmaceutical, with 999 jobs, and Merck, with 983 jobs, recorded a 19% rise and an 18% drop, respectively, while Pfizer recorded a 64% decline with a 859 new job postings during Q1 2023.
Regional analysis of hiring in the Asia-Pacific pharma industry, Q1 2023
India held the leading share of the Asia-Pacific pharma hiring activity with a 62.85% share, a 53% increase over Q4 2022. China was next with 16.53%, four-percentage-point down over the previous quarter.
What's Your Reaction?
